Who gains from saving nature
Ledger 1 : 33 — For each dollar financing nature-based solutions in 2023, about $33 financed activities harmful to nature. (UNEP)
Cases / Liability shifting (spin-offs, bankruptcy, closure bonds) · United States · 2015–2025

Chemours spin-off liabilities

Nature's voice · report
No measurement of the harm done to me here is on record.
Did nature suffer? Not measured.
Not on record
  • The record does not name which of my species, waters, soils or forests were harmed.
What the record lacks: 3 none on record · 7 insufficient · 1 not measured · 3 disputed · 2 unclear See the gaps

DuPont spun off Chemours in 2015, and DuPont's PFAS liabilities were transferred to the new company. Chemours, DuPont and Corteva have since settled PFAS claims under cost-sharing arrangements, and Chemours has sued DuPont over how the liabilities were divided.

$1.185bnPFAS settlement with US public water systems, June 2023: shared by Chemours (about $592m), DuPont (about $400m) and Corteva (about $193m)
Amounts as reported by the companies; the companies deny the allegations.

Status As of Chemours' fiscal 2025 annual report (period ended 31 December 2025): four demands for arbitration are pending against additional insurance carriers; final approval of the New Jersey settlement and of the insurance MOU had not been found.

What?
DuPont spun off Chemours in 2015 and its PFAS liabilities were transferred to it; Chemours, DuPont and Corteva have since settled PFAS claims under cost-sharing arrangements and Chemours sued DuPont over the division. PFAS Project
Where?
United States: Delaware (Chemours v DuPont), Ohio (2017 litigation and a 2023 settlement), New Jersey (2025 settlement).
When?
Separation in 2015; settlements in 2017, 2021, 2023 and 2025; insurance dealings in 2024–2025. Chemours (SEC filing)
Who?
Gained
  • DuPont — Chemours alleged that it paid DuPont a $3.9 billion dividend at the 2015 separation (allegation, not a finding). Speciality Chemicals
  • Chemours — Booked a $23 million gain on a July 2024 settlement with one insurance carrier. Chemours (SEC filing)
Lost
  • Chemours — Bears half of the January 2021 PFAS cost-sharing agreement. DuPont
  • DuPont and Corteva — Together bear the other half of the 2021 agreement, capped at $2bn. DuPont
  • Chemours, DuPont and Corteva — Paid a $1.185bn fund for US public water systems in 2023: Chemours about $592m, DuPont about $400m, Corteva about $193m. DuPont
Harmed
None on record
Why?
Chemours alleged that DuPont understated the PFAS liability passed to it by $1–2 billion at the separation; DuPont's account is not on record. Speciality Chemicals
How?
Through the 2015 spin-off, followed by cost-sharing agreements (January 2021) and settlements split between the three companies. DuPont
6 of 6 questions answered from the record

What happened

The record, in order.

DuPont spun off Chemours in 2015, and DuPont's PFAS liabilities were transferred that year to the separate company, according to a report cited in the sources reviewed. Chemours alleged that DuPont had understated its PFAS liability by $1–2 billion and that Chemours had paid DuPont a $3.9 billion dividend at the 2015 separation.

On 13 February 2017 DuPont and Chemours settled about 3,550 personal-injury suits for about $670.7 million, split 50/50, with no admission of wrongdoing. In January 2021 Chemours, DuPont and Corteva agreed to share PFAS costs 50/50 up to $4 billion over at most 20 years, with an escrow account of up to $1 billion. On 2 June 2023 the three companies agreed a $1.185 billion fund for US public water systems, and in August 2025 an agreement with New Jersey provided for $875 million in cash over 25 years, in addition to remediation funding of up to $1.2 billion and a $475 million reserve fund.

Chemours' annual report for fiscal 2025 records a July 2024 settlement with one of its insurance carriers, from which Chemours received about $23 million and booked a $23 million gain. Since April 2025, four demands for arbitration have been sent to additional insurance carriers. Under an August 2025 insurance memorandum of understanding tied to the New Jersey settlement, Chemours assigns certain PFAS insurance rights in return for $150 million.

Chemours sued DuPont in Delaware in 2019 over the division of liabilities. A PFAS Project headline of 17 December 2020 reported that a court upheld the dismissal of that lawsuit.

  1. 2005December: EPA settles a PFOA case with DuPont: $10.25m administrative penalty and a $6.25m project; DuPont does not admit liability
  2. 2015DuPont spins off Chemours; DuPont's PFAS liabilities are transferred to it
  3. 201713 February: DuPont and Chemours settle about 3,550 personal-injury suits for about $670.7m, split 50/50
  4. 2019Chemours sues DuPont in Delaware
  5. 202017 December: PFAS Project reports that a court upheld the dismissal of Chemours' lawsuit against DuPont
  6. 202122 January: Chemours, DuPont and Corteva announce a PFAS cost-sharing agreement of up to $4bn
  7. 20232 June: $1.185bn PFAS settlement with US public water systems; November–December: Ohio settlement of $110m (DuPont about $39m)
  8. 2024July: Chemours settles with one insurance carrier and receives about $23m
  9. 2025April onwards: four demands for arbitration sent to additional carriers; August: New Jersey settlement and PFAS insurance MOU

What was said

Claims, in the words of those who made them.

“In July 2024, a $45 settlement agreement was reached… with one of the insurance carriers”

Chemours, annual report (Form 10-K) for fiscal 2025 (amount in US$ millions per the sources reviewed) · FY2025 · Chemours (SEC filing)

“policy limits that total $750”

Chemours, annual report (Form 10-K) for fiscal 2025, on noticed policies not yet paid (amount in US$ millions per the sources reviewed) · FY2025 · Chemours (SEC filing)

“all claims, both decided and still pending”

Terms of the February 2017 settlement, as quoted in the sources reviewed · 13 February 2017 · CHEManager

Where accounts differ

Each party's account, side by side, with its source. The record does not settle these points; it shows them.

How were DuPont's PFAS liabilities divided at the 2015 separation?
Company or project
Chemours

Alleged that DuPont understated its PFAS liability by $1–2 billion at the 2015 separation and that Chemours paid DuPont a $3.9 billion dividend.

Speciality Chemicals
Courts
Court (not named in the sources reviewed)

A PFAS Project headline of 17 December 2020 reports that a court upheld the dismissal of Chemours' lawsuit against DuPont.

PFAS Project
Was the December 2005 EPA penalty proportionate?
Government and regulators
US Environmental Protection Agency

Announced a $10.25m administrative penalty and a $6.25m project ($16.5m in total) as the largest administrative penalty in its history. Seven of the eight counts concerned notification under TSCA section 8(e).

US Environmental Protection Agency
Communities and civil society
Environmental Working Group (EWG)

An EWG representative said existing rules allowed fines of up to $313m.

Company or project
DuPont

Did not admit liability.

US Environmental Protection Agency
How large is the August 2025 New Jersey settlement?
Company or project
Chemours

Reported $875m in cash over 25 years with a present value of about $500m at an 8% discount rate, remediation funding secured by a surety bond for four sites, and a reserve fund capped at $475m; also labelled it “the largest settlement”.

Chemours (SEC filing)
Press and investigations
WHYY

Reported the settlement as about $2bn in total.

How it looked

What was shown, beside what was recorded.

Shown

  • EPA announced the December 2005 penalty against DuPont ($10.25m administrative penalty and a $6.25m project, $16.5m in total) as the largest administrative penalty in its history.
    US Environmental Protection Agency · US Environmental Protection Agency
  • Chemours described the August 2025 New Jersey agreement as “the largest settlement”.
    Chemours
  • The companies deny the allegations in the public water systems suit.
    Chemours, DuPont and Corteva · DuPont

Recorded

  • 13 February 2017: about $671m in cash to settle about 3,550 personal-injury suits, split 50/50 between DuPont and Chemours; no admission of wrongdoing.
  • 22 January 2021: cost sharing of up to $4bn over at most 20 years, half by Chemours and half by DuPont and Corteva (their share capped at $2bn); escrow of up to $1bn, funded to 2028.
  • 2 June 2023: $1.185bn fund for US public water systems. Shares: Chemours about $592m, DuPont about $400m, Corteva about $193m.
  • August 2025, New Jersey: $875m in cash over 25 years, remediation funding of up to $1.2bn and a $475m reserve fund; shares 50% Chemours, 35.5% DuPont, 14.5% Corteva; present value of the cash about $500m at an 8% discount rate (company filing).
  • July 2024: $45m settlement with one insurance carrier, of which Chemours received about $23m and booked a $23m gain.
  • Since April 2025, four demands for arbitration sent to additional insurance carriers; noticed policies not yet paid have policy limits totalling $750m.
  • August 2025: PFAS insurance MOU tied to the New Jersey settlement; Chemours assigns certain PFAS insurance rights in return for $150m.

Who gained

Money that reached nature, beside money that stayed elsewhere.

Reached nature or the ground

Not published
No figure published.

Gained elsewhere

Not totalled
Currency: USD · Window: 2017–2025. All figures cover the same period. * Estimate built from cited figures.

Responses on record

  • chemours (June 2023): Said, with DuPont and Corteva, that the companies deny the allegations behind the $1.185bn public water systems settlement. · DuPont
  • dupont (December 2005): Did not admit liability in the December 2005 EPA settlement. · US Environmental Protection Agency
  • dupont (February 2017): Settled the February 2017 personal-injury suits with Chemours without admission of wrongdoing; said it would appeal the earlier verdicts. · CHEManager
  • chemours (FY2025): Reported in its filing a July 2024 settlement with one insurance carrier and four demands for arbitration since April 2025. · Chemours (SEC filing)
  • chemours (4 August 2025): Reported the August 2025 New Jersey terms: $875m in cash over 25 years, present value about $500m at 8%. · Chemours (SEC filing)

In court and with insurers

Every proceeding and every insurer decision on record.

Lawsuits and rulings

  1. 2005-12Settled$10250bn Administrative penalty, plus a $6.25m project
    EPA PFOA case against DuPont (December 2005)
    US Environmental Protection Agency (administrative) · Administrative · US Environmental Protection Agency → DuPont

    EPA settled for a $10.25 million administrative penalty and a $6.25 million project, announced as the largest administrative penalty in its history. Seven of the eight counts concerned TSCA section 8(e) notification. DuPont did not admit liability. US Environmental Protection Agency

  2. 2017-01Claimant won$10500bn Punitive damages (January 2017); $2m compensatory in December 2016
    PFOA personal-injury verdict (testicular cancer)
    not on record · Civil · A plaintiff with testicular cancer → DuPont

    A December 2016 verdict awarded $2 million in compensatory damages and a January 2017 verdict $10.5 million in punitive damages. The total across the three verdicts asked about was $19.7 million. DuPont said it would appeal. The Marietta Times

  3. 2017-02-13Settled$670700bn Settlement, split 50/50
    2017 personal-injury settlement (about 3,550 suits)
    2017 Ohio multidistrict litigation (as labelled in the sources reviewed) · Civil · About 3,550 personal-injury plaintiffs → DuPont and Chemours

    DuPont and Chemours settled about 3,550 cases for $670.7 million, covering “all claims, both decided and still pending”, with no admission of liability. CHEManager

  4. 2019–2020-12Dismissed
    Chemours v DuPont (separation of liabilities)
    Delaware · Civil · Chemours → DuPont

    Chemours sued DuPont in Delaware in 2019. A PFAS Project headline of 17 December 2020 reported that a court upheld the dismissal of the lawsuit. Secondary reports say the dispute was sent to closed arbitration under the separation agreement; this is not independently verified. PFAS Project

  5. 2023-06-02Settled$1185000bn Settlement fund
    US public water systems PFAS settlement
    US litigation by public water systems (court not named in the sources reviewed) · Civil · US public water systems → Chemours, DuPont and Corteva

    The three companies agreed a $1.185 billion fund on 2 June 2023, shared Chemours about $592 million, DuPont about $400 million and Corteva about $193 million. The companies deny the allegations. A judge approved the settlement, according to an ASDWA item dated 16 February 2024. DuPont

  6. 2023-12Settled$110000bn Settlement; DuPont about $39m
    Ohio settlement (November–December 2023)
    not on record · Civil · Ohio (as named in the sources reviewed) → DuPont, with other payers not named in the sources reviewed

    An Ohio settlement of $110 million was recorded in November–December 2023, of which DuPont paid about $39 million.

  7. 2025-08Settled$875000bn Cash over 25 years (present value about $500m)
    New Jersey PFAS settlement (August 2025)
    not on record · Civil · State of New Jersey → Chemours, DuPont and Corteva

    The agreement provides $875 million in cash over 25 years, remediation funding of up to $1.2 billion and a $475 million reserve fund. Shares are 50% Chemours, 35.5% DuPont and 14.5% Corteva. Final approval has not been found. Chemours (SEC filing)

  8. Outcome not on record
    California fraudulent-transfer claim over PFAS insurance rights
    not on record · Civil · California (as named in the sources reviewed) → Chemours and DuPont (as named in the sources reviewed)

    A law-firm update lists this claim as the insurance-related dispute involving Chemours and DuPont; the sources reviewed give no further detail. Simpson Thacher (stblaw.com)

Insurers

  1. 2024Partly paid$23000bn Received, from a $45m settlement agreement
    One insurance carrier (not named in the sources reviewed) → Chemours

    In July 2024 a $45 million settlement agreement was reached with one of the insurance carriers. Chemours received about $23 million and booked a $23 million gain. Chemours (SEC filing)

  2. 2025In litigation$750000bn Total policy limits on noticed policies not yet paid
    Additional noticed carriers (not named in the sources reviewed) → Chemours

    Since April 2025, four demands for arbitration have been sent to additional noticed insurance carriers. The noticed policies not yet paid have policy limits that total $750 million. Chemours (SEC filing)

  3. 2025No policy found$150000bn Consideration for assigned insurance rights
    Counterparty to the PFAS insurance MOU (not named in the sources reviewed) → Chemours

    Under an August 2025 PFAS insurance memorandum of understanding tied to the New Jersey settlement, Chemours assigns certain PFAS insurance rights in return for $150 million of consideration. Chemours (SEC filing)

What nature saw

Outcomes measured on the ground, and nature's note.

Nature's report opens this page. Below: further outcomes measured on the ground.

Public water systems fund (June 2023)
$1.185bn
Chemours about $592m, DuPont about $400m, Corteva about $193m
New Jersey cash (August 2025)
$875m over 25 years
Present value about $500m at an 8% discount rate, per the company's filing
Insurance recovered by Chemours (July 2024)
about $23m
From one carrier; noticed policies not yet paid carry limits totalling $750m

What we don't know

Undisclosed, unproven, untried: recorded as data.

Nature

  • Not measured Harm to nature: The record holds no measurement of harm to nature.

Court

  • Unclear California fraudulent-transfer claim over PFAS insurance rights: outcome not on record.

Insurers

  • Unclear Counterparty to the PFAS insurance MOU (not named in the sources reviewed): no decision on record.

Figures

  • Insufficient Business share received: Share of DuPont's business lines said to have gone to Chemours;, not independently verified.
  • Insufficient Liabilities share received: Share of environmental liabilities said to have gone to Chemours;, not independently verified.

Accounts

  • Disputed How were DuPont's PFAS liabilities divided at the 2015 separation?
  • Disputed Was the December 2005 EPA penalty proportionate?
  • Disputed How large is the August 2025 New Jersey settlement?

Record

  • None on record The 10-Ks consulted for the 2017 settlement mention no insurance.
  • None on record No documented insurance coverage denial was found for Chemours or DuPont; the insurance dispute found is California's fraudulent-transfer claim over PFAS insurance rights.
  • Insufficient Reported but not independently verified: Chemours' 2019 Delaware suit is said to have alleged that Chemours received about 19% of DuPont's business lines but two-thirds of its environmental liabilities and 90% of its litigation, that it paid DuPont a dividend of about $4 billion, and that DuPont's estimates were “systematically and extraordinarily wrong”. This comes.
  • Insufficient Reported but not independently verified: that the court sent the Chemours–DuPont dispute to closed arbitration under the separation agreement; a later appellate affirmation could not be verified.
  • Insufficient Reported but not independently verified: the 2023 water systems settlement is said to exclude personal-injury claims and state natural-resource claims.
  • Insufficient Reported but not independently verified: that the remaining cost of PFAS treatment falls on water customers, and the American Water Works Association cost estimates behind that claim.
  • Insufficient Reported but not independently verified: a June 2021 RIVM advice not to eat vegetables from home gardens within one kilometre of the Chemours plant at Dordrecht.
  • None on record Final approval of the New Jersey settlement and of the insurance MOU had not been found.

Did the harm stop?

Who paid?

The 2017 settlement was split 50/50 between DuPont and Chemours. In the 2021 agreement Chemours bears half and DuPont and Corteva together bear half, capped at $2bn. The 2023 fund was shared Chemours about $592m, DuPont about $400m, Corteva about $193m. The New Jersey shares are 50% Chemours, 35.5% DuPont and 14.5% Corteva.

Sources

Voices on record: ✓ Company or project✓ Government and regulators— Courts✓ Press and investigations✓ Communities and civil society— Researchers

Government and regulators

  1. EPA settles PFOA case against DuPont (archived EPA news release)
    US Environmental Protection Agency · 2005-12

Connected cases

Related matters, and cases linked to this one through the same organisations, with the role each played in both.

Science and environment

PFOA (C8) and PFAS
PFAS are a large family of human-made chemicals that persist in the environment and the body; PFOA, also called C8, is one of them and was used to make Teflon.

Law and courts

Arbitration
A private dispute process in which an appointed arbitrator, instead of a court, decides the case.
Punitive damages
Money a court orders a defendant to pay to punish especially reckless conduct, on top of compensation for losses. Mainly used in US courts.

Bonds and banking

Delaware, Guernsey, Cayman Islands
Jurisdictions widely used to register companies, funds and accounts for legal, confidentiality and tax reasons.

Institutions

EPA
The US Environmental Protection Agency.
SEC
The US Securities and Exchange Commission, which regulates securities markets and what companies tell investors.